Dale, David C.
Crawford, Jeffrey
Klippel, Zandra
Reiner, Maureen
Osslund, Timothy
Fan, Ellen
Morrow, Phuong Khanh
Allcott, Kim
Lyman, Gary H.
Funding for this research was provided by:
Amgen Inc
Article History
Received: 8 March 2017
Accepted: 15 August 2017
First Online: 22 September 2017
Compliance with ethical standards
:
: David Dale has received research support from and is a consultant for Amgen Inc. Jeffrey Crawford has received research support from Amgen Inc., AstraZeneca, Bayer, Clovis, and GTx; has been a scientific advisor for Merck, Novartis, and Pfizer; and has participated as a member of a data and safety monitoring board for Celgene, G1 Therapeutics, Janssen, Merrimack, and Roche. Zandra Klippel, Maureen Reiner, Timothy Osslund, Ellen Fan, and Phuong Khanh Morrow are employees of and own stock in Amgen Inc. Kim Allcott is an employee of Oxford PharmaGenesis Ltd., which has received project funding from Amgen Inc. and Amgen (Europe) GmbH. Gary Lyman has received research support from Amgen Inc.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Formal consent was not required, as the article does not contain any studies involving human participants performed by any of the authors.